Search company, investor...

Predict your next investment

JIC Venture Growth Investments company logo
Venture Capital
j-vgi.co.jp

Investments

57

Portfolio Exits

3

Funds

2

About JIC Venture Growth Investments

JIC Venture Growth Investments contributes to strengthening industrial competitiveness by supplying sufficient venture capital to growth areas based on industrial policy and collaborating with private businesses.

Headquarters Location

21st floor of Marunouchi Eiraku Building 1-4-1, Marunouchi, Chiyoda-ku

Tokyo, 100-0005,

Japan

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest JIC Venture Growth Investments News

Metagen Therapeutics Closes 1.7 Billion Yen Series A Financing

Jun 15, 2023

Metagen Therapeutics, a Tsuruoka, Japan-based company focusing on drug discovery and development based on intestinal microbiome-based therapeutics for various diseases, completed its Series A funding in 2 rounds, raising a total of 1.7 billion yen. Sparx Asset Management, Nippon Venture Capital, Mizuho Capital and SMBC Venture Capital have joined the 1st round investors of JIC Venture Growth Investments, a type of sovereign wealth fund in Japan, JAFCO, Japan’s largest venture capital company, Fast Track Initiative and Keio Innovation Initiative. With the closing of the 2nd round, Metagen Therapeutics has raised a total amount of 1.93 billion yen since its inception. The company intends to use the funds for: 1. Development and operation of the intestinal microbiota bank Development of registration system for intestinal microbiota donor candidates Operation of intestinal microbiota bank (in accordance with institutional guidelines) – Donor recruitment/online interview, donor eligibility evaluation, intake of stool donations, manufacturing/assessment/storage of intestinal microbiota solution Establishing process regarding preparation and quality control for intestinal microbiota solution 2. Promotion of basic and clinical research for clinical application of FMT (such as joint research related to immune checkpoint inhibitors) 3. Research and development of intestinal microbiota drug discovery program (including probiotics) Founded by researchers of Juntendo University, Keio University and Tokyo Institute of Technology in 2020 and led by President & CEO Taku Nakahara, Metagen Therapeutics is a biotech startup focused on drug discovery and medical business through microbiota therapeutics. The company has been accelerating its drug discovery and development work on intestinal microbiome-based therapeutics for various diseases such as cancer, ulcerative colitis, and Parkinson’s disease. It aims for social impact through medical care and drug discovery. FinSMEs

JIC Venture Growth Investments Investments

57 Investments

JIC Venture Growth Investments has made 57 investments. Their latest investment was in PRD Therapeutics as part of their Series A on October 10, 2023.

CBI Logo

JIC Venture Growth Investments Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/6/2023

Series A

PRD Therapeutics

$8.72M

Yes

2

7/3/2023

Series A - II

Toregem BioPharma

$2.63M

Yes

3

6/13/2023

Series A - II

LayerX

$19.22M

Yes

3

6/7/2023

Series C

Subscribe to see more

$99M

Subscribe to see more

10

6/5/2023

Series B - II

Subscribe to see more

Subscribe to see more

10

Date

10/6/2023

7/3/2023

6/13/2023

6/7/2023

6/5/2023

Round

Series A

Series A - II

Series A - II

Series C

Series B - II

Company

PRD Therapeutics

Toregem BioPharma

LayerX

Subscribe to see more

Subscribe to see more

Amount

$8.72M

$2.63M

$19.22M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

3

3

10

10

JIC Venture Growth Investments Portfolio Exits

3 Portfolio Exits

JIC Venture Growth Investments has 3 portfolio exits. Their latest portfolio exit was CUORiPS on June 27, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/27/2023

IPO

$99M

Public

2

3/29/2023

IPO

Subscribe to see more

$99M

Subscribe to see more

10

3/28/2023

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/27/2023

3/29/2023

3/28/2023

Exit

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

2

10

10

JIC Venture Growth Investments Fund History

2 Fund Histories

JIC Venture Growth Investments has 2 funds, including JIC Venture Growth Fund No. 2.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/16/2022

JIC Venture Growth Fund No. 2

$14.64M

1

JIC Venture Growth Fund No. 1

$99M

10

Closing Date

12/16/2022

Fund

JIC Venture Growth Fund No. 2

JIC Venture Growth Fund No. 1

Fund Type

Status

Amount

$14.64M

$99M

Sources

1

10

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.